These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24395429)

  • 1. Arctigenin enhances chemosensitivity to cisplatin in human nonsmall lung cancer H460 cells through downregulation of survivin expression.
    Wang HQ; Jin JJ; Wang J
    J Biochem Mol Toxicol; 2014 Jan; 28(1):39-45. PubMed ID: 24395429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arctigenin enhances chemosensitivity of cancer cells to cisplatin through inhibition of the STAT3 signaling pathway.
    Yao X; Zhu F; Zhao Z; Liu C; Luo L; Yin Z
    J Cell Biochem; 2011 Oct; 112(10):2837-49. PubMed ID: 21608020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promotion of p53 expression and reactive oxidative stress production is involved in zerumbone-induced cisplatin sensitization of non-small cell lung cancer cells.
    Hu Z; Zeng Q; Zhang B; Liu H; Wang W
    Biochimie; 2014 Dec; 107 Pt B():257-62. PubMed ID: 25220870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
    Wong JC; Bathina M; Fiscus RR
    J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effects of ADAM8 against cisplatin-mediated apoptosis in non-small-cell lung cancer.
    Zhang W; Wan M; Ma L; Liu X; He J
    Cell Biol Int; 2013 Jan; 37(1):47-53. PubMed ID: 23319321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arctigenin induces cell cycle arrest by blocking the phosphorylation of Rb via the modulation of cell cycle regulatory proteins in human gastric cancer cells.
    Jeong JB; Hong SC; Jeong HJ; Koo JS
    Int Immunopharmacol; 2011 Oct; 11(10):1573-7. PubMed ID: 21621647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2 downregulation sensitizes nonsmall cell lung cancer cells to cisplatin, but not to docetaxel.
    Losert D; Pratscher B; Soutschek J; Geick A; Vornlocher HP; Müller M; Wacheck V
    Anticancer Drugs; 2007 Aug; 18(7):755-61. PubMed ID: 17581297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arctigenin promotes apoptosis in ovarian cancer cells via the iNOS/NO/STAT3/survivin signalling.
    Huang K; Li LA; Meng YG; You YQ; Fu XY; Song L
    Basic Clin Pharmacol Toxicol; 2014 Dec; 115(6):507-11. PubMed ID: 24842412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
    Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
    Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arctigenin anti-tumor activity in bladder cancer T24 cell line through induction of cell-cycle arrest and apoptosis.
    Yang S; Ma J; Xiao J; Lv X; Li X; Yang H; Liu Y; Feng S; Zhang Y
    Anat Rec (Hoboken); 2012 Aug; 295(8):1260-6. PubMed ID: 22619087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD44 inhibition attenuates EGFR signaling and enhances cisplatin sensitivity in human EGFR wild‑type non‑small‑cell lung cancer cells.
    Yin J; Zhang H; Wu X; Zhang Y; Li J; Shen J; Zhao Y; Xiao Z; Lu L; Huang C; Zhang Z; Du F; Wu Y; Kaboli PJ; Cho CH; Yuan D; Li M
    Int J Mol Med; 2020 Jun; 45(6):1783-1792. PubMed ID: 32236608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of arctigenin on human rheumatoid arthritis fibroblast-like synoviocytes.
    Liu H; Yang Y; Cai X; Gao Y; Du J; Chen S
    Pharm Biol; 2015 Aug; 53(8):1118-23. PubMed ID: 25609147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of Meg3 enhances cisplatin resistance of lung cancer cells through activation of the WNT/β-catenin signaling pathway.
    Xia Y; He Z; Liu B; Wang P; Chen Y
    Mol Med Rep; 2015 Sep; 12(3):4530-4537. PubMed ID: 26059239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of OCT4B enhances sensitivity of lung adenocarcinoma A549 cells to cisplatin via increased apoptosis.
    Cortes-Dericks L; Yazd EF; Mowla SJ; Schmid RA; Karoubi G
    Anticancer Res; 2013 Dec; 33(12):5365-73. PubMed ID: 24324071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel compound PS-101 exhibits selective inhibition in non-small-cell lung cancer cell by blocking the EGFR-driven antiapoptotic pathway.
    Zhang GH; Cai LJ; Wang YF; Zhou YH; An YF; Liu YC; Peng Y; Chen ZF; Liang H
    Biochem Pharmacol; 2013 Dec; 86(12):1721-30. PubMed ID: 24161785
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of XIAP in inhibiting cisplatin-induced caspase activation in non-small cell lung cancer cells: a small molecule Smac mimic sensitizes for chemotherapy-induced apoptosis by enhancing caspase-3 activation.
    Checinska A; Hoogeland BS; Rodriguez JA; Giaccone G; Kruyt FA
    Exp Cell Res; 2007 Apr; 313(6):1215-24. PubMed ID: 17291493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Relationship between survivin expression and chemosensitivity of human lung cancer cells].
    Yang H; Fu JH; Hu Y; Huang WZ; Zheng B; Wang G
    Zhonghua Yi Xue Za Zhi; 2007 Jul; 87(27):1934-7. PubMed ID: 17923022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sorafenib induces apoptotic cell death in human non-small cell lung cancer cells by down-regulating mammalian target of rapamycin (mTOR)-dependent survivin expression.
    Kim YS; Jin HO; Seo SK; Woo SH; Choe TB; An S; Hong SI; Lee SJ; Lee KH; Park IC
    Biochem Pharmacol; 2011 Aug; 82(3):216-26. PubMed ID: 21601561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. XIAP-mediated protection of H460 lung cancer cells against cisplatin.
    Cheng YJ; Jiang HS; Hsu SL; Lin LC; Wu CL; Ghanta VK; Hsueh CM
    Eur J Pharmacol; 2010 Feb; 627(1-3):75-84. PubMed ID: 19903469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of thymidine phosphorylase expression by using an HSP90 inhibitor potentiates the cytotoxic effect of cisplatin in non-small-cell lung cancer cells.
    Weng SH; Tseng SC; Huang YC; Chen HJ; Lin YW
    Biochem Pharmacol; 2012 Jul; 84(1):126-36. PubMed ID: 22480737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.